Literature DB >> 3969618

Revascularization of popliteal and below-knee arteries with polytetrafluoroethylene.

J T Christenson, A Broomé, L Norgren, B Eklöf.   

Abstract

The expanded polytetrafluoroethylene (PTFE) graft (Gore-tex) is the most frequently used synthetic graft when an alternative to autologous saphenous vein is required. Early results have been encouraging. In the present paper we report on 6 years of results from 153 above-knee (AK) femoropopliteal bypass grafts, 74 below-knee (BK) femoropopliteal bypass grafts, and 54 femorotibial/peroneal bypass grafts. The main indication for the vascular reconstruction was severe ischemia. Preventive antibiotics were given to 95% of the patients. Minimum observation time was 1 year after implantation. There was no operative death. Graft infection was seen in less than 5% of patients. The 6-year cumulative limb salvage rate was 87% for patients with severe ischemia in the AK femoropopliteal bypass group, 59% for those in the BK femoropopliteal bypass group, and 57% for those in the femorotibial/peroneal bypass group. The graft patency rate was 88% at 2 years and 78% at 6 years for the AK femoropopliteal bypass group, for whom the operative indication was disabling claudication, and 81% and 68%, respectively, when the indication for the vascular procedure was severe ischemia. The cumulative graft patency rate was 53% and 43% at 2 and 6 years, respectively, after implantation of BK femoropopliteal bypass grafts and 43% and 39% for femorotibial/peroneal bypass procedures. The expanded PTFE (Gore-tex) graft seems therefore to be a good alternative when an autologous vein is not available, even for reconstructions well below the knee joint.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3969618

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  3 in total

Review 1.  Engineering of bypass conduits to improve patency.

Authors:  S T Rashid; H J Salacinski; B J Fuller; G Hamilton; A M Seifalian
Journal:  Cell Prolif       Date:  2004-10       Impact factor: 6.831

2.  Reversed vein bypass to infrapopliteal arteries. Modern results are superior to or equivalent to in-situ bypass for patency and for vein utilization.

Authors:  L M Taylor; J M Edwards; E S Phinney; J M Porter
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

3.  Saphenous vein is by far superior to PTFE as a femoropopliteal bypass.

Authors:  M E McClurken
Journal:  Ann Surg       Date:  1986-11       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.